These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7259794)

  • 21. Local anesthetics, chlorpromazine and propranolol inhibit stimulus-activation of phospholipase A2 in human platelets.
    Vanderhoek JY; Feinstein MB
    Mol Pharmacol; 1979 Jul; 16(1):171-80. PubMed ID: 384205
    [No Abstract]   [Full Text] [Related]  

  • 22. Diethylaminoethoxyhexestrol inhibition of purified rat liver lysosomal phospholipase A1: role of drug binding to substrate.
    Kubo M; Hostetler KY
    J Pharmacol Exp Ther; 1987 Jan; 240(1):88-92. PubMed ID: 3027309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimentally induced lipidosis in uterine and vaginal epithelium of rats.
    Geist SH; Lüllmann-Rauch R
    Ann Anat; 1994 Jan; 176(1):3-9. PubMed ID: 8304588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of liver lysosomal acid phospholipase A1 by blood serum proteins.
    Löffler BM; Bohn E; Kunze H
    Biochem Int; 1988 Nov; 17(5):965-71. PubMed ID: 3254168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic basis of diethylaminoethoxyhexestrol-induced phospholipid fatty liver.
    Kubo M; Hostetler KY
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E375-9. PubMed ID: 3030133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fusion of storage lysosomes in experimental lipidosis and glycogenosis.
    Lüllmann-Rauch R; Watermann D
    Exp Mol Pathol; 1987 Feb; 46(1):136-43. PubMed ID: 3467980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet.
    Bronner C; Wiggins C; Monté D; Märki F; Capron A; Landry Y; Franson RC
    Biochim Biophys Acta; 1987 Aug; 920(3):301-5. PubMed ID: 3607084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipidosislike renal changes in rats treated with chlorphentermine or with tricyclic antidepressants.
    Lüllmann-Rauch B
    Virchows Arch B Cell Pathol; 1975; 18(1):51-60. PubMed ID: 167510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chloroquine keratopathy as an example of drug-induced phospholipidosis (contribution to the pathogenesis of cornea verticillata) (author's transl)].
    Seiler KU; Thiel HJ; Wassermann O
    Klin Monbl Augenheilkd; 1977 Jan; 170(1):64-73. PubMed ID: 15159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antimalarial drugs on several rat-liver lysosomal enzymes involved in phosphatidylethanolamine catabolism.
    Kunze H; Hesse B; Bohn E
    Biochim Biophys Acta; 1982 Oct; 713(1):112-7. PubMed ID: 7138892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y; Angevine LS; Mehendale HM
    Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipidosis-like alterations in spinal cord and cerebellar cortex of rats treated with chlorphentermine or tricylic antidepressants.
    Lüllmann-Rauch R
    Acta Neuropathol; 1974; 29(3):237-49. PubMed ID: 4446950
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chloroquine- and chlorphentermin-induced lipidosis in rat retina].
    Bredehorn T; Duncker GI
    Klin Monbl Augenheilkd; 1999 Mar; 214(3):178-82. PubMed ID: 10220731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal lysosomal protein digestion in experimental lipidosis.
    Christensen EI; Maunsbach AB; Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 43(3):309-16. PubMed ID: 6137902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition of lysosomal phospholipase A from rabbit lung by ambroxol and its consequences for pulmonary surfactant.
    Heath MF; Jacobson W
    Lung; 1985; 163(6):337-44. PubMed ID: 3937951
    [No Abstract]   [Full Text] [Related]  

  • 36. Intraalveolar foam cells associated with lipidosis-like alterations in lung and liver of rats treated with tricyclic psychotropic drugs.
    Lüllmann-Rauch R; Scheid D
    Virchows Arch B Cell Pathol; 1975 Nov; 19(3):255-68. PubMed ID: 174284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of liver lysosomal acid phospholipase A1.
    Kunze H; Bohn E; Löffler BM
    Eur J Biochem; 1988 Nov; 177(3):591-5. PubMed ID: 3197719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corneal lipidosis in rats treated with amphiphilic cationic drugs.
    Drenckhahn D; Jacobi B; Lüllmann-Rauch R
    Arzneimittelforschung; 1983; 33(6):827-31. PubMed ID: 6684436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anterior polar cataract and lysosomal alterations in the lens of rats treated with the amphiphilic lipidosis-inducing drugs chloroquine and chlorphentermine.
    Drenckhahn D
    Virchows Arch B Cell Pathol; 1978 May; 27(3):255-66. PubMed ID: 208230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Freeze-fracture studies of cytoplasmic inclusions occurring in experimental lipidosis as induced by amphiphilic cationic drugs.
    Buchheim W; Drenckhahn D; Lüllmann-Rauch R
    Biochim Biophys Acta; 1979 Oct; 575(1):71-80. PubMed ID: 228737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.